AG Campbell announced an agreement with the Trump administration to prevent further delays in critical medical and public health research. The agreement resolves Massachusetts’ challenge to the administration’s suspension of federal funding for embryonic stem cell and other health research projects — a move that threatened the progress of lifesaving medical studies and the state’s research institutions. 
 
“This agreement ensures that critical medical research projects are able to continue, paving the way for lifesaving medical advancements, driving job creation, and fostering academic competitiveness at Massachusetts’s world class research institutions.” – AG Campbell